<p>根据 Atlas Capital Advisors Inc.最近向证券交易委员会（SEC）提交的 13F 文件，该公司在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）中的持股在第一季度增加了 1,463.2%。该机构投资者在此期间购买了额外的 15,817 股后，持有该药房运营商的 16,898 股股票。根据其最近向证券交易委员会（SEC）提交的文件，Atlas Capital Advisors Inc.在 CVS Health 的持股价值为 1,145,000 美元。</p>
<ul>
<li>MarketBeat 周报 – 05/12 - 05/16</li>
</ul>
<p>其他一些对冲基金最近也买卖了该股票的股份。先锋集团（Vanguard Group Inc.）在第一季度将其在 CVS Health 的股份增加了 0.8%。先锋集团目前拥有 118,335,394 股该药房运营商的股票，价值 8,017,223,000 美元，此前在上个季度又收购了 969,027 股。道奇与考克斯（Dodge &amp; Cox）在第四季度将其在 CVS Health 的股份增加了 11.2%。道奇与考克斯目前拥有 70,105,899 股该药房运营商的股票，价值 3,147,054,000 美元，此前在上个季度又收购了 7,075,209 股。资本世界投资者（Capital World Investors）在第四季度将其在 CVS Health 的股份增加了 26.6%。资本世界投资者目前拥有 61,039,777 股该药房运营商的股票，价值 2,739,927,000 美元，此前在上个季度又收购了 12,819,148 股。资本国际投资者（Capital International Investors）在第四季度将其在 CVS Health 的股份增加了 4.8%。资本国际投资者目前拥有 26,666,401 股该药房运营商的股票，价值 1,196,989,000 美元，此前在上个季度又收购了 1,212,126 股。最后，查尔斯·施瓦布投资管理公司（Charles Schwab Investment Management Inc.）在第一季度将其在 CVS Health 的股份增加了 5.6%。查尔斯·施瓦布投资管理公司目前拥有 13,647,873 股该药房运营商的股票，价值 924,643,000 美元，此前在上个季度又购买了 728,924 股。机构投资者和对冲基金持有该公司 80.66% 的股份。</p>
<h2>CVS Health 的内部交易</h2>
<p>在相关消息中，董事 Guy P. Sansone 于 6 月 5 日（星期四）购买了 1,570 股该公司的股票。该股票的平均购买成本为每股 63.70 美元，总价值为 100,009.00 美元。收购完成后，该董事直接持有公司 12,007 股，价值 764,845.90 美元。此次交易使其持股增加了 15.04%。该收购已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。公司内部人士持有该公司 1.22% 的股份。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>现在是购买诺和诺德股票的好时机吗？</li>
</ul>
<p>一些研究公司最近对 CVS 发布了报告。巴克莱（Barclays）在 8 月 1 日（星期五）的研究报告中将 CVS Health 的目标股价从 79.00 美元上调至 80.00 美元，并给予该股票 “超配” 评级。伯恩斯坦银行（Bernstein Bank）在 7 月 16 日（星期三）的研究报告中将 CVS Health 的目标股价从 78.00 美元下调至 72.00 美元，并对该股票给予 “市场表现” 评级。杰富瑞金融集团（Jefferies Financial Group）在 6 月 30 日（星期一）的研究报告中将 CVS Health 的目标股价从 74.00 美元上调至 80.00 美元，并给予该股票 “买入” 评级。加拿大皇家银行（Royal Bank Of Canada）在 5 月 5 日（星期一）的研究报告中将 CVS Health 的目标股价从 74.00 美元上调至 81.00 美元，并给予该股票 “跑赢大盘” 评级。最后，富国银行（Wells Fargo &amp; Company）在 5 月 6 日（星期二）的研究报告中重申了 “超配” 评级，并将 CVS Health 的目标股价设定为 84.00 美元（之前为 76.00 美元）。三位股票研究分析师对该股票给予持有评级，十八位给予买入评级，一位给予强烈买入评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，共识目标股价为 75.11 美元。</p>
<p><strong>查看我们关于 CVS Health 的最新研究报告</strong></p>
<h2>CVS Health 股票表现</h2>
<ul>
<li>在业绩疲软和 CVS-诺和诺德合作后，艾利利（Eli Lilly）值得购买吗？</li>
</ul>
<p>CVS 股票在星期五开盘价为 65.49 美元。该股票的 50 日移动平均价格为 64.68 美元，200 日移动平均价格为 64.23 美元。该股票的市值为 830.6 亿美元，市盈率为 18.29，市盈增长比率为 0.70，贝塔值为 0.58。CVS Health Corporation 的 1 年最低价为 43.56 美元，1 年最高价为 72.51 美元。该公司的债务股本比率为 0.74，速动比率为 0.62，流动比率为 0.80。</p>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 7 月 31 日（星期四）发布了季度财报。该药房运营商报告本季度每股收益（EPS）为 1.81 美元，超出市场共识预期的 1.46 美元，超出 0.35 美元。该公司本季度的收入为 989.2 亿美元，而分析师预期为 948.7 亿美元。CVS Health 的股本回报率为 10.51%，净利润率为 1.17%。CVS Health 的收入同比增长 8.4%。在去年同期，该公司每股收益为 1.83 美元。卖方分析师预测 CVS Health Corporation 在本财年将发布 5.89 美元的每股收益。</p>
<h2>CVS Health 股息公告</h2>
<p>该公司最近还披露了季度股息，该股息于 8 月 1 日（星期五）支付。7 月 22 日（星期二）的登记投资者获得每股 0.665 美元的股息。该股息的除息日为 7 月 22 日（星期二）。这代表着每年 2.66 美元的股息和 4.1% 的收益率。CVS Health 的派息比率目前为 74.30%。</p>
<h2>CVS Health 简介</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 CVS Health 更好的股票</li>
<li>市盈率计算：如何评估股票</li>
<li>MarketBeat 周回顾 – 08/04 - 08/08</li>
<li>商业服务股票投资</li>
<li>Airbnb 超出预期盈利，但增长故事正在失去高度</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>Netflix 的多头与空头：谁将在这次回调中获胜？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>Atlas Capital Advisors Inc. 在第一季度显著增加了对 CVS Health Corporation 的持股，增幅达到 1,463.2%，目前持有 16,898 股，价值 1,145,000 美元。其他机构投资者，包括先锋集团和道奇与考克斯，也提高了他们的持仓。CVS Health 的股票共识评级为 “适度买入”，目标价为 75.11 美元。该股票开盘价为 65.49 美元，市值为 830.6 亿美元，市盈率为 18.29。过去一年中，CVS Health 的股票价格在 43.56 美元至 72.51 美元之间波动</p>

<p>Atlas Capital Advisors Inc. raised its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 1,463.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,898 shares of the pharmacy operator's stock after purchasing an additional 15,817 shares during the period. Atlas Capital Advisors Inc.'s holdings in CVS Health were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>根据 Atlas Capital Advisors Inc.最近向证券交易委员会（SEC）提交的 13F 文件，该公司在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）中的持股在第一季度增加了 1,463.2%。该机构投资者在此期间购买了额外的 15,817 股后，持有该药房运营商的 16,898 股股票。根据其最近向证券交易委员会（SEC）提交的文件，Atlas Capital Advisors Inc.在 CVS Health 的持股价值为 1,145,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 05/12 - 05/16</li>
</ul>
</div><p>A number of other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of CVS Health by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock worth $8,017,223,000 after acquiring an additional 969,027 shares in the last quarter. Dodge &amp; Cox raised its position in shares of CVS Health by 11.2% during the 4th quarter. Dodge &amp; Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after acquiring an additional 7,075,209 shares in the last quarter. Capital World Investors raised its position in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after acquiring an additional 12,819,148 shares in the last quarter. Capital International Investors raised its position in shares of CVS Health by 4.8% during the 4th quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock worth $1,196,989,000 after acquiring an additional 1,212,126 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in CVS Health by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock worth $924,643,000 after buying an additional 728,924 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也买卖了该股票的股份。先锋集团（Vanguard Group Inc.）在第一季度将其在 CVS Health 的股份增加了 0.8%。先锋集团目前拥有 118,335,394 股该药房运营商的股票，价值 8,017,223,000 美元，此前在上个季度又收购了 969,027 股。道奇与考克斯（Dodge &amp; Cox）在第四季度将其在 CVS Health 的股份增加了 11.2%。道奇与考克斯目前拥有 70,105,899 股该药房运营商的股票，价值 3,147,054,000 美元，此前在上个季度又收购了 7,075,209 股。资本世界投资者（Capital World Investors）在第四季度将其在 CVS Health 的股份增加了 26.6%。资本世界投资者目前拥有 61,039,777 股该药房运营商的股票，价值 2,739,927,000 美元，此前在上个季度又收购了 12,819,148 股。资本国际投资者（Capital International Investors）在第四季度将其在 CVS Health 的股份增加了 4.8%。资本国际投资者目前拥有 26,666,401 股该药房运营商的股票，价值 1,196,989,000 美元，此前在上个季度又收购了 1,212,126 股。最后，查尔斯·施瓦布投资管理公司（Charles Schwab Investment Management Inc.）在第一季度将其在 CVS Health 的股份增加了 5.6%。查尔斯·施瓦布投资管理公司目前拥有 13,647,873 股该药房运营商的股票，价值 924,643,000 美元，此前在上个季度又购买了 728,924 股。机构投资者和对冲基金持有该公司 80.66% 的股份。</p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的内部交易</h2>
</div><p>In related news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director directly owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.22% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Guy P. Sansone 于 6 月 5 日（星期四）购买了 1,570 股该公司的股票。该股票的平均购买成本为每股 63.70 美元，总价值为 100,009.00 美元。收购完成后，该董事直接持有公司 12,007 股，价值 764,845.90 美元。此次交易使其持股增加了 15.04%。该收购已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。公司内部人士持有该公司 1.22% 的股份。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是购买诺和诺德股票的好时机吗？</li>
</ul>
</div><p>A number of research firms recently issued reports on CVS. Barclays raised their price target on CVS Health from $79.00 to $80.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, August 1st. Bernstein Bank dropped their price target on CVS Health from $78.00 to $72.00 and set a &#34;market perform&#34; rating on the stock in a research note on Wednesday, July 16th. Jefferies Financial Group raised their price target on CVS Health from $74.00 to $80.00 and gave the stock a &#34;buy&#34; rating in a research note on Monday, June 30th. Royal Bank Of Canada raised their price target on CVS Health from $74.00 to $81.00 and gave the stock an &#34;outperform&#34; rating in a research note on Monday, May 5th. Finally, Wells Fargo &amp; Company restated an &#34;overweight&#34; rating and set a $84.00 price target (up previously from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $75.11.</p>
<div class="lb-trans"><p>一些研究公司最近对 CVS 发布了报告。巴克莱（Barclays）在 8 月 1 日（星期五）的研究报告中将 CVS Health 的目标股价从 79.00 美元上调至 80.00 美元，并给予该股票 “超配” 评级。伯恩斯坦银行（Bernstein Bank）在 7 月 16 日（星期三）的研究报告中将 CVS Health 的目标股价从 78.00 美元下调至 72.00 美元，并对该股票给予 “市场表现” 评级。杰富瑞金融集团（Jefferies Financial Group）在 6 月 30 日（星期一）的研究报告中将 CVS Health 的目标股价从 74.00 美元上调至 80.00 美元，并给予该股票 “买入” 评级。加拿大皇家银行（Royal Bank Of Canada）在 5 月 5 日（星期一）的研究报告中将 CVS Health 的目标股价从 74.00 美元上调至 81.00 美元，并给予该股票 “跑赢大盘” 评级。最后，富国银行（Wells Fargo &amp; Company）在 5 月 6 日（星期二）的研究报告中重申了 “超配” 评级，并将 CVS Health 的目标股价设定为 84.00 美元（之前为 76.00 美元）。三位股票研究分析师对该股票给予持有评级，十八位给予买入评级，一位给予强烈买入评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，共识目标股价为 75.11 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on CVS Health</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS Health 的最新研究报告</strong></p>
</div><h2>CVS Health Stock Performance</h2>
<div class="lb-trans"><h2>CVS Health 股票表现</h2>
</div><ul>
<li>Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?</li>
</ul>
<div class="lb-trans"><ul>
<li>在业绩疲软和 CVS-诺和诺德合作后，艾利利（Eli Lilly）值得购买吗？</li>
</ul>
</div><p>Shares of CVS stock opened at $65.49 on Friday. The stock has a fifty day moving average price of $64.68 and a 200 day moving average price of $64.23. The stock has a market cap of $83.06 billion, a PE ratio of 18.29, a P/E/G ratio of 0.70 and a beta of 0.58. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80.</p>
<div class="lb-trans"><p>CVS 股票在星期五开盘价为 65.49 美元。该股票的 50 日移动平均价格为 64.68 美元，200 日移动平均价格为 64.23 美元。该股票的市值为 830.6 亿美元，市盈率为 18.29，市盈增长比率为 0.70，贝塔值为 0.58。CVS Health Corporation 的 1 年最低价为 43.56 美元，1 年最高价为 72.51 美元。该公司的债务股本比率为 0.74，速动比率为 0.62，流动比率为 0.80。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%. CVS Health's revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.83 earnings per share. Sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 7 月 31 日（星期四）发布了季度财报。该药房运营商报告本季度每股收益（EPS）为 1.81 美元，超出市场共识预期的 1.46 美元，超出 0.35 美元。该公司本季度的收入为 989.2 亿美元，而分析师预期为 948.7 亿美元。CVS Health 的股本回报率为 10.51%，净利润率为 1.17%。CVS Health 的收入同比增长 8.4%。在去年同期，该公司每股收益为 1.83 美元。卖方分析师预测 CVS Health Corporation 在本财年将发布 5.89 美元的每股收益。</p>
</div><h2>CVS Health Dividend Announcement</h2>
<div class="lb-trans"><h2>CVS Health 股息公告</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.1%. CVS Health's payout ratio is currently 74.30%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，该股息于 8 月 1 日（星期五）支付。7 月 22 日（星期二）的登记投资者获得每股 0.665 美元的股息。该股息的除息日为 7 月 22 日（星期二）。这代表着每年 2.66 美元的股息和 4.1% 的收益率。CVS Health 的派息比率目前为 74.30%。</p>
</div><h2>CVS Health Profile</h2>
<div class="lb-trans"><h2>CVS Health 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>P/E Ratio Calculation: How to Assess Stocks</li>
<li>MarketBeat Week in Review – 08/04 - 08/08</li>
<li>Business Services Stocks Investing</li>
<li>Airbnb Beats Earnings, But the Growth Story Is Losing Altitude</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>Netflix Bulls vs. Bears: Who Wins This Pullback?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 CVS Health 更好的股票</li>
<li>市盈率计算：如何评估股票</li>
<li>MarketBeat 周回顾 – 08/04 - 08/08</li>
<li>商业服务股票投资</li>
<li>Airbnb 超出预期盈利，但增长故事正在失去高度</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>Netflix 的多头与空头：谁将在这次回调中获胜？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Atlas Capital Advisors Inc. 购入了西维斯健康公司（NYSE:CVS）的股票